A Case of Severe Intractable Contamination-Based Obsessive-Compulsive Disorder

Brian P. Brennan; Ryan J. Jacoby; Alik S. Widge

doi:10.1001/jamapsychiatry.2018.0927

A Case of Severe Intractable Contamination-Based Obsessive-Compulsive Disorder

Brian P. Brennan, Ryan J. Jacoby, Alik S. Widge

Research output: Contribution to journal › Comment/debate › peer-review

Original language	English (US)
Pages (from-to)	1088-1089
Number of pages	2
Journal	JAMA psychiatry
Volume	75
Issue number	10
DOIs	https://doi.org/10.1001/jamapsychiatry.2018.0927
State	Published - Oct 2018
Externally published	Yes

Bibliographical note

Funding Information:
received research grant funding from Eli Lilly and Company, Transcept Pharmaceuticals (now Paratek Pharmaceuticals), and Biohaven Pharmaceuticals and consulting fees from Rugen Therapeutics and Nobilis Therapeutics Inc. Dr Widge has received device donations and consulting fees from Medtronic and has pending patent applications related to deep brain stimulation. No other disclosures are reported.

Access

10.1001/jamapsychiatry.2018.0927

OpenUrl availability

Full text

Cite this

@article{ec3c5463a53945aea5ed4c7aa820b515,

title = "A Case of Severe Intractable Contamination-Based Obsessive-Compulsive Disorder",

author = "Brennan, {Brian P.} and Jacoby, {Ryan J.} and Widge, {Alik S.}",

note = "Funding Information: received research grant funding from Eli Lilly and Company, Transcept Pharmaceuticals (now Paratek Pharmaceuticals), and Biohaven Pharmaceuticals and consulting fees from Rugen Therapeutics and Nobilis Therapeutics Inc. Dr Widge has received device donations and consulting fees from Medtronic and has pending patent applications related to deep brain stimulation. No other disclosures are reported.",

year = "2018",

month = oct,

doi = "10.1001/jamapsychiatry.2018.0927",

language = "English (US)",

volume = "75",

pages = "1088--1089",

journal = "JAMA psychiatry",

issn = "2168-622X",

publisher = "American Medical Association",

number = "10",

}

TY - JOUR

T1 - A Case of Severe Intractable Contamination-Based Obsessive-Compulsive Disorder

AU - Brennan, Brian P.

AU - Jacoby, Ryan J.

AU - Widge, Alik S.

N1 - Funding Information: received research grant funding from Eli Lilly and Company, Transcept Pharmaceuticals (now Paratek Pharmaceuticals), and Biohaven Pharmaceuticals and consulting fees from Rugen Therapeutics and Nobilis Therapeutics Inc. Dr Widge has received device donations and consulting fees from Medtronic and has pending patent applications related to deep brain stimulation. No other disclosures are reported.

PY - 2018/10

Y1 - 2018/10

UR - http://www.scopus.com/inward/record.url?scp=85053060733&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85053060733&partnerID=8YFLogxK

U2 - 10.1001/jamapsychiatry.2018.0927

DO - 10.1001/jamapsychiatry.2018.0927

M3 - Comment/debate

C2 - 30128485

AN - SCOPUS:85053060733

SN - 2168-622X

VL - 75

SP - 1088

EP - 1089

JO - JAMA psychiatry

JF - JAMA psychiatry

IS - 10

ER -

A Case of Severe Intractable Contamination-Based Obsessive-Compulsive Disorder

Bibliographical note

Access

OpenUrl availability

Other files and links

Cite this